Suven Life Sciences Limited

NSEI:SUVEN Stock Report

Market Cap: ₹30.9b

Suven Life Sciences Management

Management criteria checks 2/4

Suven Life Sciences' CEO is Venkat Jasti, appointed in Oct 2004, has a tenure of 35.58 years. directly owns 0.001% of the company’s shares, worth ₹312.32K. The average tenure of the management team and the board of directors is 9.4 years and 6.4 years respectively.

Key information

Venkat Jasti

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure20yrs
CEO ownership0.001%
Management average tenure9.4yrs
Board average tenure6.4yrs

Recent management updates

Recent updates

Suven Life Sciences (NSE:SUVEN) Is In A Good Position To Deliver On Growth Plans

Oct 26
Suven Life Sciences (NSE:SUVEN) Is In A Good Position To Deliver On Growth Plans

Companies Like Suven Life Sciences (NSE:SUVEN) Are In A Position To Invest In Growth

Jun 21
Companies Like Suven Life Sciences (NSE:SUVEN) Are In A Position To Invest In Growth

How Much Did Suven Life Sciences'(NSE:SUVEN) Shareholders Earn From Share Price Movements Over The Last Year?

Aug 26
How Much Did Suven Life Sciences'(NSE:SUVEN) Shareholders Earn From Share Price Movements Over The Last Year?

CEO Compensation Analysis

How has Venkat Jasti's remuneration changed compared to Suven Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-₹1b

Mar 31 2024n/an/a

-₹1b

Dec 31 2023n/an/a

-₹1b

Sep 30 2023n/an/a

-₹1b

Jun 30 2023n/an/a

-₹1b

Mar 31 2023n/an/a

-₹1b

Dec 31 2022n/an/a

-₹1b

Sep 30 2022n/an/a

-₹940m

Jun 30 2022n/an/a

-₹991m

Mar 31 2022n/an/a

-₹1b

Dec 31 2021n/an/a

-₹1b

Sep 30 2021n/an/a

-₹1b

Jun 30 2021n/an/a

-₹1b

Mar 31 2021n/an/a

-₹722m

Dec 31 2020n/an/a

-₹761m

Sep 30 2020n/an/a

-₹745m

Jun 30 2020n/an/a

-₹787m

Mar 31 2020n/an/a

-₹942m

Dec 31 2019n/an/a

₹28m

Sep 30 2019n/an/a

₹1b

Jun 30 2019n/an/a

₹871m

Mar 31 2019₹58m₹29m

-₹239m

Mar 31 2018₹47m₹25m

₹1b

Compensation vs Market: Insufficient data to establish whether Venkat's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Venkat's compensation has increased whilst the company is unprofitable.

CEO

Venkat Jasti (75 yo)

20yrs

Tenure

Mr. Venkateswarlu Jasti, also known as Venkat, M.Pharm. M.S., is Member of Advisory Council of Suven Pharmaceuticals Limited since 2024. Mr. Jasti served as Executive Director at Suven Pharmaceuticals Limi...

Leadership Team

NamePositionTenureCompensationOwnership
Venkateswarlu Jasti
CEO & Director20yrsno data0.0010%
₹ 312.3k
Sudharani Jasti
Whole-Time Director35.6yrs₹9.99m0.70%
₹ 216.7m
Vivek Sharma
Executive Chairmanless than a yearno datano data
M. Kumar
Chief Financial Officer4.8yrsno datano data
Kundan Jha
Company Secretary & Compliance Officerless than a yearno datano data
Kalyani Jasti
President of US Operations14.1yrsno data0.00046%
₹ 142.2k

9.4yrs

Average Tenure

70yo

Average Age

Experienced Management: SUVEN's management team is seasoned and experienced (9.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Venkateswarlu Jasti
CEO & Director35.6yrsno data0.0010%
₹ 312.3k
Sudharani Jasti
Whole-Time Director35.6yrs₹9.99m0.70%
₹ 216.7m
Vivek Sharma
Executive Chairmanless than a yearno datano data
Seyed Hasnain
Non-Independent & Non-Executive Director14.5yrs₹200.00kno data
Santanu Mukherjee
Independent Non-Executive Director6.4yrs₹250.00kno data
Jasthi Ananthasai Padmaja
Independent Non-Executive Director5.9yrs₹110.00kno data
Vajja Rao
Independent Directorless than a yearno datano data

6.4yrs

Average Tenure

70yo

Average Age

Experienced Board: SUVEN's board of directors are considered experienced (6.4 years average tenure).